We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
+7.52%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.7B
AUM Growth
+$539M
Cap. Flow
-$486M
Cap. Flow %
-2.59%
Top 10 Hldgs %
25.55%
Holding
3,078
New
21
Increased
334
Reduced
2,669
Closed
33

Top Buys

Rank Stock Value
1
AVTR icon
Avantor
AVTR
+$19.6M
2
PLTR icon
Palantir
PLTR
+$15.2M
3
AAPL icon
Apple
AAPL
+$12.8M
4
CNH
CNH Industrial
CNH
+$10.5M
5
WAL icon
Western Alliance Bancorporation
WAL
+$9.86M

Sector Composition

Rank Sector Weight
1 Technology 28.58%
2 Financials 12.72%
3 Healthcare 11.35%
4 Consumer Discretionary 11.12%
5 Industrials 10.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCEL icon
2401
Avita Medical
RCEL
$306M
$146K ﹤0.01%
13,664
-84
-0.6% -$789
CIVB icon
2402
Civista Bancshares
CIVB
$571M
$146K ﹤0.01%
8,197
-51
-0.6% -$854
RM icon
2403
Regional Management Corp
RM
$304M
$146K ﹤0.01%
4,458
+100
+2% +$3.1K
OUST icon
2404
Ouster
OUST
$2.55B
$146K ﹤0.01%
23,136
-143
-0.6% -$1.36K
ACIC icon
2405
American Coastal Insurance
ACIC
$441M
$146K ﹤0.01%
12,922
-80
-0.6% -$894
AVAH icon
2406
Aveanna Healthcare
AVAH
$3.07B
$145K ﹤0.01%
27,946
-172
-0.6% -$778
ITOS
2407
DELISTED
iTeos Therapeutics
ITOS
$145K ﹤0.01%
14,228
+262
+2% +$4K
KRO icon
2408
KRONOS Worldwide
KRO
$937M
$145K ﹤0.01%
11,640
-72
-0.6% -$833
ITCI
2409
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$145K ﹤0.01%
1,976
-71
-3% -$5.34K
INZY
2410
DELISTED
Inozyme Pharma
INZY
$145K ﹤0.01%
27,641
-170
-0.6% -$882
IMMR icon
2411
Immersion
IMMR
$246M
$144K ﹤0.01%
16,175
-101
-0.6% -$1.03K
VYGR icon
2412
Voyager Therapeutics
VYGR
$197M
$144K ﹤0.01%
24,597
-152
-0.6% -$1.1K
QTTB icon
2413
Q32 Bio
QTTB
$330M
$144K ﹤0.01%
3,223
-21
-0.6% -$772
THRD
2414
DELISTED
Third Harmonic Bio
THRD
$144K ﹤0.01%
10,601
-66
-0.6% -$818
ALDX icon
2415
Aldeyra Therapeutics
ALDX
$80.8M
$144K ﹤0.01%
26,637
-165
-0.6% -$785
MEC icon
2416
Mayville Engineering Co
MEC
$487M
$143K ﹤0.01%
6,801
-43
-0.6% -$805
VNDA icon
2417
Vanda Pharmaceuticals
VNDA
$308M
$143K ﹤0.01%
30,479
-188
-0.6% -$1.01K
SMAR
2418
DELISTED
Smartsheet Inc.
SMAR
$142K ﹤0.01%
2,568
+46
+2% +$2.23K
CZFS icon
2419
Citizens Financial Services
CZFS
$395M
$142K ﹤0.01%
2,439
-17
-0.7% -$854
PHLT
2420
DELISTED
Performant Healthcare Inc
PHLT
$141K ﹤0.01%
37,819
-232
-0.6% -$793
PKOH icon
2421
Park-Ohio Holdings
PKOH
$673M
$141K ﹤0.01%
4,592
-27
-0.6% -$764
SAVE
2422
DELISTED
Spirit Airlines, Inc.
SAVE
$141K ﹤0.01%
58,693
-363
-0.6% -$999
SFST icon
2423
Southern First Bancshares
SFST
$598M
$141K ﹤0.01%
4,127
-26
-0.6% -$837
TBCH
2424
Turtle Beach Corp
TBCH
$229M
$141K ﹤0.01%
9,164
-56
-0.6% -$817
WOW
2425
DELISTED
WideOpenWest
WOW
$140K ﹤0.01%
26,735
+235
+0.9% +$1.25K

Similar funds

Corebridge Financial's Q3 2024 Portfolio in Review

As of Q3 2024, Corebridge Financial held 3,078 positions worth $18.7B, up 3% from $18.2B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 1.8%. Corebridge Financial opened 21 new positions and exited 33, leaving the 3,078-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.

  • Corebridge Financial's largest Q3 2024 buy was Dell: 70,274 shares worth $8.33M.
  • Corebridge Financial added most to Avantor in Q3 2024, an estimated $19.6M increase.
  • Corebridge Financial's biggest Q3 2024 reduction was Microsoft, cutting an estimated $29.5M.
  • Corebridge Financial fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $10.1M.
  • Corebridge Financial's ten largest holdings make up 26% of its $18.7B portfolio in Q3 2024.
  • Corebridge Financial opened 21 new positions and closed 33 in Q3 2024.
  • Corebridge Financial's portfolio value rose 3% quarter-over-quarter to $18.7B.

Based on Corebridge Financial's 13F filing for Q3 2024, filed 13 Nov 2024.